The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

Share Price Information for Mandarin In.sg (MDO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.06
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.06
MDO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REDEVELOPMENT OF THE EXCELSIOR, HONG KONG

9 Oct 2018 07:00

RNS Number : 3410D
Mandarin Oriental International Ltd
09 October 2018
 

 

To: Business Editor For immediate release

 

This announcement contains Inside Information.

 

REDEVELOPMENT OF THE EXCELSIOR, HONG KONG

 

9th October 2018 - Mandarin Oriental International Limited today announces that The Excelsior, Hong Kong will close on 31st March 2019 in order for Mandarin Oriental Hotel Group (the 'Group') to redevelop the site. The hotel is situated on a prime commercial waterfront site in the Causeway Bay district of Hong Kong where the Group has approval for the development of a mixed-use commercial building with a Gross Floor Area of some 63,500 sqm.

 

The decision to close the hotel, which opened in 1973, comes after having completed a detailed review of the long-term strategic options for the site, announced by the Group in June 2017. The decision reflects strong commercial property values in Hong Kong and the expected higher yield associated with a commercial building at a time when the hotel requires significant investment.

 

The wholly-owned Excelsior hotel is a material contributor to Group earnings and cash flows and houses the Group's corporate office. Adjusting the Group's reported results for 2016 and 2017, and the first half of 2018 to exclude the contribution of The Excelsior, and include an estimated incremental head office rent cost, generates the following pro forma results[1]:

 

 

 

US$m

2016

Reported

(Audited)

2016

Pro Forma

(Unaudited)

 

2017

Reported

(Audited)

2017

Pro Forma

(Unaudited)

 

H1 2018

Reported

(Unaudited)

H1 2018

Pro Forma

(Unaudited)

Revenue*

1,323.7

1,245.2

 

1,380.4

1,298.2

 

700.2

660.0

Underlying EBITDA

158.2

126.2

 

157.9

122.9

 

79.6

63.6

Underlying Profit

57.3

34.4

 

54.9

29.8

 

22.3

11.4

Net impact to cash

 

(19.3)

 

 

(21.6)

 

 

(15.1)

* Total revenue from owned & managed hotels

Upon closure of the hotel, the Group will be required to recognise a one-time accounting valuation gain associated with reclassifying the asset as a commercial investment property on its balance sheet. Based on current assumptions and market information, the Group estimates that this reclassification of the asset to reflect its market value as a site for commercial redevelopment would lead to an accounting gain of some US$2.9 billion (net of closure costs).

 

The redevelopment is expected to take up to six years to complete and cost some US$650 million. The redevelopment will be funded through an appropriate mix of external debt and cash reserves. A decision on financing will be made in due course, with the majority of costs not expected to be incurred until 2023. The Excelsior site is mortgage free. Approximately US$15 million of costs related to the redevelopment are estimated to be incurred in 2019, which the Group will fund from cash reserves. At 30th June 2018, the Group had net debt of US$325 million, with gearing of 6% (measured as a percentage of net debt against adjusted shareholders' funds[2]).

 

While Group earnings will be lower during the redevelopment period due to lost earnings from The Excelsior, the Group's results will soon benefit from the re-opening of its hotels in London and Madrid which are currently under renovation. Once completed, the new building is expected to generate significantly higher, and more stable, cash flows with less ongoing capital expenditure compared to a renovated hotel. The redevelopment itself is not expected to adversely impact the recent level of dividends paid.

 

James Riley, Group Chief Executive of Mandarin Oriental Hotel Group, said "The Excelsior has always been an important and much-loved hotel in the Group's portfolio. We will ensure there are plenty of opportunities over the next few months for local and international guests to visit the property and celebrate 45 years of memories. The hotel has enjoyed a long and successful history, not least because of the extraordinary service provided by our colleagues on property through the years. The Group is committed to ensuring that all Excelsior colleagues are treated fairly, with many to be offered positions in other Mandarin Oriental properties."

 

Mandarin Oriental currently operates 31 hotels and seven residences in 21 countries and territories. Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

Jill Kluge (44) 20 7908 7831

Sally de Souza (852) 2895 9167

 

Brunswick Group Limited

Karin Wong (852) 3512 5077

Elizabeth Liang (852) 3512 5058

Tom Burns (44) 20 7396 5308

 

This and other Group announcements can be accessed through the internet at 'www.mandarinoriental.com'.

 

[1] The Pro Forma numbers presented have not been audited and are shown for illustrative purposes only.

[2] The Group's freehold and leasehold interests are carried in the consolidated balance sheet at amortised cost. The adjusted shareholders' funds for 30th June 2018 were adjusted to include the market value of the Group's freehold and leasehold interests appraised at 31st December 2017. The market value assumed for The Excelsior Hotel was that of a site for commercial redevelopment and not that for an operating hotel.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDMPBFTMBBMBJP
Date   Source Headline
9th Apr 202410:28 amRNSAnnual Financial Report
25th Mar 20249:26 amRNSBLOCK LISTING INTERIM REVIEW
7th Mar 202410:04 amRNS2023 Preliminary Results
1st Mar 20249:25 amRNSCHANGE OF SINGAPORE BRANCH REGISTRAR
22nd Dec 20231:18 pmRNSMO Signs Option to sell MO, Paris
24th Nov 20239:22 amRNSDirectorate Change
9th Nov 20239:54 amRNSINTERIM MANAGEMENT STATEMENT
27th Sep 202310:28 amRNSDividend Declaration
25th Sep 202310:33 amRNSBlock listing Interim Review
1st Sep 202310:27 amRNSDirector Declaration
28th Jul 202310:33 amRNSHalf-year Results
18th May 202310:23 amRNSInterim Management Statement
4th May 202312:31 pmRNSResult of AGM
2nd May 202310:17 amRNSDirectorate Change
3rd Apr 202310:26 amRNSAnnual Financial Report
31st Mar 202310:24 amRNSTotal Voting Rights
27th Mar 202310:30 amRNSBlock listing Interim Review
2nd Mar 202310:27 amRNSAudit Committee Chairman and Membership Changes
2nd Mar 20239:30 amRNSMandarin Oriental - 2022 Preliminary Results
31st Jan 202310:49 amRNSTotal Voting Rights
10th Nov 20229:42 amRNSInterim Management Statement
26th Sep 202210:21 amRNSBlock listing Interim Review
28th Jul 202210:28 amRNSHalf Year Results
18th Jul 20225:19 pmRNSMO announces Sale of MO, Washington D.C.
19th May 202210:27 amRNSInterim Management Statement
5th May 202212:40 pmRNSResult of AGM
7th Apr 202210:35 amRNSAnnual Financial Report
31st Mar 202211:34 amRNSTotal Voting Rights
25th Mar 20229:28 amRNSBlock listing Interim Review
3rd Mar 20229:29 amRNS2021 Preliminary Announcement of Results
31st Jan 20227:18 amRNSTotal Voting Rights
31st Dec 20217:01 amRNSTotal Voting Rights
30th Nov 20219:43 amRNSTotal Voting Rights
19th Nov 20219:28 amRNSDirectorate Change
11th Nov 20219:41 amRNSInterim Management Statement
22nd Oct 202110:18 amRNSDirectorate Change
27th Sep 202110:23 amRNSBlock listing Interim Review
30th Jul 202110:20 amRNSTotal Voting Rights
29th Jul 202110:38 amRNSDirectorate Change
29th Jul 202110:23 amRNS2021 HALF YEAR FINANCIAL STATEMENTS
30th Jun 202110:21 amRNSTotal Voting Rights
1st Jun 20217:02 amRNSTotal Voting Rights
20th May 20217:00 amRNSDirectorate Change
5th May 20211:25 pmRNSResult of AGM
5th May 202110:24 amRNSInterim Management Statement
30th Apr 202110:30 amRNSTotal Voting Rights
16th Apr 202110:26 amRNSHolding(s) in Company
8th Apr 202110:31 amRNSAnnual Financial Report
25th Mar 20219:27 amRNSBlock listing Interim Review
24th Mar 20219:47 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.